编辑:产前抗精神病药物暴露的神经发育结果
1Riverside University Health System, Riverside, California.
概括
在怀孕期间使用抗精神病药物正在增加,但高质量的安全证据是有限的. 医生需要更多的数据来指导孕妇的治疗决定.
科学领域:
- 生产周围精神病学
- 在怀孕期间的药物监测
- 生殖毒理学
背景情况:
- 孕妇使用抗精神病药物在2001年至2010年间显著增加.
- 在此期间,非典型的抗精神病药物被处方给超过150万名有医疗补助保险的孕妇.
- 双极性障碍是首要诊断的药物,氨酸和阿里皮普拉是最常用的药物.
研究的目的:
- 为了突出孕妇使用抗精神病药物的趋势.
- 强调需要对这些药物的安全性进行更多研究.
- 为医疗保健提供者提供有关当前处方模式和相关诊断趋势的信息.
主要方法:
- 分析大量有医疗补助保险的孕妇的处方数据.
- 检查2001年至2010年间的药物发行趋势.
- 确定主要诊断和最常使用的抗精神病药物.
主要成果:
- 在2001年至2010年期间, 超过150万名受 Medicaid 医疗补助的孕妇处方了非典型的抗精神病药物.
- 在这一群体中,抗精神病药物的使用率从0. 4%增加到1. 3%.
- 双极性障碍是首要诊断的药物,氨酸和阿里皮普拉是最常用的药物.
结论:
- 怀孕中抗精神病药物的使用增加需要紧急临床关注和进一步的安全研究.
- 双极性障碍是孕妇使用抗精神病药物的关键症状.
- 奎蒂亚平和阿里皮普拉在围产期精神病治疗中占据着重要地位,因此需要进行具体的安全性评估.
更多相关视频
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.5K
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
329
相关概念视频
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Psychological and Sociocultural Causes of Schizophrenia
977
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
977
Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449
Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
